Washington DC (STL.News) – The Securities and Exchange Commission today charged TherapeuticsMD Inc., a pharmaceutical company headquartered in Boca Raton, Florida, with violations of Regulation FD based on its sharing of material, nonpublic information with sell-side research analysts without also disclosing the same information to the public.

The SEC’s order finds that on two separate occasions in 2017, Therapeuticsmd selectively shared material information with analysts about the company’s interactions with the U.S.

Continue reading SEC News: SEC Charges Therapeuticsmd With Regulation FD Violations at STL.News.